T cell-mediated modulation of mast cell function: Heterotypic adhesion-induced stimulatory or inhibitory effects

Frontiers in Immunology

Volumn 3, Issue JAN, 2012, Pages

  Mekori, Yoseph A ^a,b   Hershko, Alon Y ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Heterotypic adhesion; Mast cells; Microvesicles; T cells

Indexed keywords

EID: 84874091270     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00006     Document Type: Short Survey

References (34)

1. Al-Nedawwi, K., Meehan, B., and Rak, J. (2009). Microvesicles. Cell Cycle 8, 2014-2018.
2. Bachelet, I., Levi-Schaffer, F., and Mekori, Y. A. (2006). Mast cells, not only in allergy. Immunol. Allergy Clin. North Am. 26, 407-426.
3. Baram, D., Dekel, O., Mekori, Y. A., and Sagi-Eisenberg, R. (2010). Activa- tion of mast cells by trimeric G pro- tein Gi3; coupling to the A3 adeno- sine receptor directly, and upon T cell contact. J. Immunol. 184, 3677-3688.
4. Baram, D., Vaday, G. G., Salamon, P., Drucker, I., Hershkovis, R., and Mekori, Y. A. (2001). Human mast cells release metalloproteinase-9 on contact with activated T cells: jux- tacrine regulation by TNF-α. J. Immunol. 167, 4008-4016.
5. Bhattacharyya, S. P., Drucker, I., Reshef, T., Kirshenbaum, A. S., Metcalfe, D. D., and Mekori, Y. A. (1998). Acti- vated lymphocytes induce degranu- lation and cytokine production by human mast cells following cell to cell contact. J. Leukoc. Biol. 63, 337-341.
6. Biedermann, T., Kneilling, M., Mail- hammer, R., Maier, K., Sander, C. A., Kollias, G., Kunkel, S. L., Hult- ner, L., and Rocken, M. (2000). Mast cells controlneutrophil recruitment during T cell mediateddelayed-type hypersensitivity. J. Exp. Med. 192, 1441-1452.
7. Brill, A., Baram, D., Sela, U., Salamon, P., Mekori, Y. A., and Hershkovis, R. (2004). Induction of mast cell inter- actions with blood vessel wall com- ponents by direct contact with intact T cells or T cell membranes in vitro. Clin. Exp. Allergy 34, 1725-1731.
8. Dudeck, A., Dudeck, J., Scholten, J., Pet- zold, A., Surianarayanan, S., Kohler, A., Peshcke, K., Vohringer, D., Was- cow, C., Krieg, T., Muller, W., Wais- mann, A., Hartmann, K., Gunzer, M., and Roers, A. (2011). Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34, 973-984.
9. Eller,K.,Wolf,D.,Huber,J. M.,Metz,M., Mayer, G., McKenzie, A. N., Mau- rer, M., Rosenkranz, A. R., and Wolf, A. M. (2011). IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J. Immunol. 186, 83-91.
10. Feng, L. L., Gao, J. M., Li, P. P., and Wang, X. (2011). IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-Hodgkin's lymphoma. J. Clin. Immunol. 31, 1084-1094.
11. Frossi, B., D'Inca, F., Crivellato, E., Sibilano, R., Gri, G., Mongillo, M., Danelli, L., Maggi, L., and Pucillo, C. E. (2011). Single-cell dynamics of mast cell-CD4+CD25+ regulatory T cell interactions. Eur. J. Immunol. 41, 1872-1882.
12. Frossi, B., Gri, G., Tripodo, C., and Pucillo, C. (2010). Exploring a regu- latory role for mast cells: "MCregs?" Trends. Immunol. 3, 97-102.
13. Gounaris, E., Blatner, N. R., Dennis, K., Magnusson, F., Gurish, M. F., Strom, T. B., Beckhove, P., Gounari, F., and Khazaie, K. (2009). T- regulatory cells shift from a protec- tive anti-inflammatory to a cancer- promoting pro-inflammatory phe- notype in polyposis. Cancer Res. 69, 5490-5497.
14. Gri, G., Piconese, S., Frossi, B., Manfroi, V., Merluzzi, S., Tripodo, C., Viola, A., Odom, S., Rivera, J., Colombo, M. P., and Pucillo, C. E. (2008). CD4+CD25+ regulatory T cells sup- press mast cell degranulation and allergic responses through OX40- OX40L interaction. Immunity 29, 771-781.
15. Hershko, A. Y., and Rivera, J. (2010). Mast cell and T cell communication; amplification and control of adap- tive immunity. Immunol. Lett. 128, 98-104.
16. Hershko, A. Y., Suzuki, R., Charles, N., Alvarez-Errico, D., Sargent, J., Lau- rence, A., and Rivera, J. (2011). Mast cell interleukin-2 production con- tributes to suppression of chronic allergic dermatitis. Immunity 35, 562-571.
17. Inamura, N., Mekori, Y. A., Bhat- tacaryya, S. P., Bianchine, P. J., and Metcalfe, D. D. (1998). Induction and enhancement of FCεRI- dependent mast cell degranulation following coculture with activated T cells: dependency on ICAM-1 and leukocyte function-associated antigen (LFA)-1-mediated het- erotypic aggregation. J. Immunol. 160, 4026-4033.
18. Kalesnikoff, J., and Galli, S. J. (2008). New developments in mast cell biology. Nat. Immunol. 9, 1215-1223.
19. Kayshap, M., Thornton, A. M., Norton, S. K., Barnstein, B., Macey, M., Bren- zovich, J., Shevach, E., Leonard, W. J., and Ryan, J. J. (2008). Cutting edge: CD4 T cell-mast cell inter- actions alter IgE receptor expres- sion and signaling. J. Immunol. 180, 2039-2043.
20. Lu, L. F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., Strom, T. B., Zheng, X. X., and Noelle, R. J. (2006). Mast cells are essentials intermediaries in regula- tory T-cell tolerance. Nature 442, 997-1002.
21. Mekori, Y. A. (2004). The masto- cyte: the other inflammatory cell in immunopathogenesis. J. Allergy Clin. Immunol. 114, 52-57.
22. Mor, A., Shefler, I., Salamon, P., Kloog, Y., and Mekori, Y. A. (2010). Char- acterization of ERK activation by human mast cells stimulated by con- tact with activated T cells. Inflamma- tion 33, 119-125.
23. Salamon, P., Shoham, N. G., Gavrieli, R., Wolach, B., and Mekori, Y. A. (2005). Human mast cells release interleukin-8 and induce neutrophil chemotaxis on contact with activated T cells. Allergy 60, 1316-1319.
24. Salamon, P., Shoham, N. G., Puxeddu, I., Paitan, Y., Levi-schaffer, F., and Mekori, Y. A. (2008). Human mast cells release oncostatin M on contact with activated T cells: possible biologic relevance. J. Allergy Clin. Immunol. 121, 448-455.
25. Shefler, I., Mekori, Y. A., and Mor, A. (2008). Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing pro- tein 1. J. Allergy Clin. Immunol. 122, 1222-1225.
26. Shefler, I., Salamon, P., Hershko, A. Y., and Mekori, Y. A. (2011). Mast cells as sources and targets of membrane microvesicles. Curr. Pharm. Des. 17, 3797-3804.
27. Shefler, I., Salamon, P., Mor, A., and Mekori, Y. A. (2010). T cell induced mast cell activation: a role for microparticles released from acti- vated T cells. J. Immunol. 185, 4206-4212.
28. Shevach, E. M. (2004). Regula- tory/suppressor T cells in health and disease. Arthritis Rheum. 50, 2721-2724.
29. Shevach, E. M. (2006). From vanilla to 28 flavors: multiple varieties of T regulatory cells. Immunity 25, 195-201.
30. Sibilano, R., Gri, G., Frossi, B., Tripodo, C., Suzuki, R., Rivera, J., Macdonald, A. S., and Pucillo, C. E. (2011). Tech- nical advance: soluble OX40 mole- cule mimics regulatory T cell modu- latory activity on FCeRI-dependent mast cell degranulation. J. Leukoc. Biol. 90, 831-838.
31. Stelekati, E., Bahri, R., DwOrlando, O., Orinska, Z., Mittrucker, H.-W., Lan- genhaun, R., Glatzel, M., Bollinger, A., Paus, R., and Bulfone-Paus, S. (2009). Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions. Immunity 31, 665-676.
32. Stopfer, P., Mannel, D. N., and Hehl- gans, T. (2004). Lymphotoxin-beta receptor activation by T cells induces cytokine release from mouse bone marrow-derived mast cells. J. Immunol. 172, 7459-7465
33. Thery, C., Ostrowski, M., and Segura, E. (2009). Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581-593.
34. Yang, Z., Zhang, B., Li, D., Lu, M., Huang, C., Shen, G. X., and Huang, B. (2010). Mast cells mobilize myeloid-derived sup- pressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepato- carcinoma. PLoS ONE 5, e8922. doi:10.1371/journal.pone.0008922